These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 18684125)
1. A survey of adherence to haemophilia therapy in six European countries: results and recommendations. De Moerloose P; Urbancik W; Van Den Berg HM; Richards M Haemophilia; 2008 Sep; 14(5):931-8. PubMed ID: 18684125 [TBL] [Abstract][Full Text] [Related]
2. Current prescription of prophylactic factor infusions and perceived adherence for children and adolescents with haemophilia: a survey of haemophilia healthcare professionals in the United States. Thornburg CD; Carpenter S; Zappa S; Munn J; Leissinger C Haemophilia; 2012 Jul; 18(4):568-74. PubMed ID: 22335526 [TBL] [Abstract][Full Text] [Related]
3. Prophylaxis therapy in paediatric patients with haemophilia: a survey of clinical management trends in Italy. Castaman G; Rocino A; Mazzucconi MG; Zanon E; Gagliano F; Molinari AC Blood Transfus; 2015 Oct; 13(4):631-8. PubMed ID: 26057481 [TBL] [Abstract][Full Text] [Related]
4. Joint outcomes in patients with haemophilia: the importance of adherence to preventive regimens. Berntorp E Haemophilia; 2009 Nov; 15(6):1219-27. PubMed ID: 19659939 [TBL] [Abstract][Full Text] [Related]
5. Adherence to prophylactic treatment in patients with haemophilia in Germany. Miesbach W; Kalnins W Haemophilia; 2016 Sep; 22(5):e367-74. PubMed ID: 27353213 [TBL] [Abstract][Full Text] [Related]
6. Tailored frequency-escalated primary prophylaxis for severe haemophilia A: results of the 16-year Canadian Hemophilia Prophylaxis Study longitudinal cohort. Feldman BM; Rivard GE; Babyn P; Wu JKM; Steele M; Poon MC; Card RT; Israels SJ; Laferriere N; Gill K; Chan AK; Carcao M; Klaassen RJ; Cloutier S; Price VE; Dover S; Blanchette VS Lancet Haematol; 2018 Jun; 5(6):e252-e260. PubMed ID: 29731369 [TBL] [Abstract][Full Text] [Related]
7. Haemophilia prophylaxis: a model and future directions in Jordan. Awidi A; Faouri S; Kiswani BA; Al-Sweedan S; Albarqawi M; Bsoul N; Haddadin I; Al-Falah M; Telfah A; Hermans C Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s343-4. PubMed ID: 24120588 [No Abstract] [Full Text] [Related]
8. Musculoskeletal evaluation in severe haemophilia A patients from Latin America. Ozelo MC; Villaça PR; Pérez-Bianco R; Candela M; Garcia-Chavez J; Moreno-Rodriguez B; Rodrigues MB; Rodriguez-Grecco I; Solano MH; Chumpitaz G; Morales-Gana MM; Ruiz-Sáez A Haemophilia; 2014 Jan; 20(1):e63-70. PubMed ID: 24354487 [TBL] [Abstract][Full Text] [Related]
9. Current situation of regular replacement therapy (prophylaxis) for haemophilia in Japan. Taki M; Shirahata A Haemophilia; 2009 Jan; 15(1):78-82. PubMed ID: 18700841 [TBL] [Abstract][Full Text] [Related]
10. Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors. Fischer K; Valentino L; Ljung R; Blanchette V Haemophilia; 2008 Jul; 14 Suppl 3():196-201. PubMed ID: 18510542 [TBL] [Abstract][Full Text] [Related]
11. Choice of factor VIII/IX regimen in adolescents and young adults with severe or moderately severe haemophilia. A French national observational study (ORTHem 15-25). Meunier S; d'oiron R; Chambost H; Dolimier E; Guillet B; Thromb Res; 2017 Mar; 151():17-22. PubMed ID: 28088606 [TBL] [Abstract][Full Text] [Related]
12. Treatment patterns, health-related quality of life and adherence to prophylaxis among haemophilia A patients in the United States. Duncan N; Shapiro A; Ye X; Epstein J; Luo MP Haemophilia; 2012 Sep; 18(5):760-5. PubMed ID: 22548353 [TBL] [Abstract][Full Text] [Related]
13. The use of prophylaxis in 2663 children and adults with haemophilia: results of the 2006 Canadian national haemophilia prophylaxis survey. Biss TT; Chan AK; Blanchette VS; Iwenofu LN; McLimont M; Carcao MD; ; Haemophilia; 2008 Sep; 14(5):923-30. PubMed ID: 18637844 [TBL] [Abstract][Full Text] [Related]
14. Preference-based valuation of treatment attributes in haemophilia A using web survey. Steen Carlsson K; Andersson E; Berntorp E Haemophilia; 2017 Nov; 23(6):894-903. PubMed ID: 28851125 [TBL] [Abstract][Full Text] [Related]
15. Relationship between factor VIII replacement therapy and joint damage in severe haemophilia. Lowe GD Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S3-5. PubMed ID: 9351528 [TBL] [Abstract][Full Text] [Related]
16. The overall effectiveness of prophylaxis in severe haemophilia. Panicker J; Warrier I; Thomas R; Lusher JM Haemophilia; 2003 May; 9(3):272-8. PubMed ID: 12694517 [TBL] [Abstract][Full Text] [Related]
17. Quality-of-life differences between prophylactic and on-demand factor replacement therapy in European haemophilia patients. Royal S; Schramm W; Berntorp E; Giangrande P; Gringeri A; Ludlam C; Kroner B; Szucs T; Haemophilia; 2002 Jan; 8(1):44-50. PubMed ID: 11886464 [TBL] [Abstract][Full Text] [Related]
18. An objective method for assessing adherence to prophylaxis in adults with severe haemophilia. Ho S; Gue D; McIntosh K; Bucevska M; Yang M; Jackson S Haemophilia; 2014 Jan; 20(1):39-43. PubMed ID: 23919911 [TBL] [Abstract][Full Text] [Related]
19. Orthopaedic evaluation in children with severe haemophilia A or B submitted to primary prophylaxis therapy in a coagulopathy treatment centre. De Podestá Haje D; Ono F; De Oliveira GB; Almeida J; De Paula JC; Batista Neto LV; Silva Barros SB Haemophilia; 2011 Mar; 17(2):228-32. PubMed ID: 21070500 [TBL] [Abstract][Full Text] [Related]
20. The European Principles of Haemophilia Care: a pilot investigation of adherence to the principles in Europe. Fischer K; Hermans C; Haemophilia; 2013 Jan; 19(1):35-43. PubMed ID: 22931302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]